Positions

Instructor in the Department of Medicine in the School of Medicine

2020 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2022 School of Medicine

Education

M.D., Duke University, School of Medicine 1989

1989 Duke University, School of Medicine

Residency, Brigham and Women's Hospital, INTERNAL MEDICINE 1990 - 1992

1992 Brigham and Women's Hospital

Fellowship, Dana Farber Cancer Institute, MEDICAL ONCOLOGY 1992 - 1995

1995 Dana Farber Cancer Institute

Publications, Grants & Awards

• Academics Articles (13)
• Conference Pages (1)

Showing 1 - 5 of 13

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease.

April 20, 2020J Clin Oncol

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantatio

December 20, 2017J Clin Oncol

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

May 01, 2017Biol Blood Marrow Transplant

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

April 10, 2017J Clin Oncol

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

June 01, 2016J Clin Oncol